Riemersma SA - Search Results

1

Flow cytometric sorting of paraffin-embedded tumor tissues considerably improves molecular genetic analysis.

Jordanova ES, Corver WE, Vonk MJ, Leers MP, Riemersma SA, Schuuring E, Kluin PM. Jordanova ES, et al. Among authors: riemersma sa. Am J Clin Pathol. 2003 Sep;120(3):327-34. doi: 10.1309/HPR1-1R7L-Q9NN-CCG8. Am J Clin Pathol. 2003. PMID: 14502796

2

Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.

Jordanova ES, Riemersma SA, Philippo K, Giphart-Gassler M, Schuuring E, Kluin PM. Jordanova ES, et al. Among authors: riemersma sa. Genes Chromosomes Cancer. 2002 Sep;35(1):38-48. doi: 10.1002/gcc.10093. Genes Chromosomes Cancer. 2002. PMID: 12203788

3

Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.

Jordanova ES, Riemersma SA, Philippo K, Schuuring E, Kluin PM. Jordanova ES, et al. Among authors: riemersma sa. Int J Cancer. 2003 Jan 20;103(3):393-8. doi: 10.1002/ijc.10824. Int J Cancer. 2003. PMID: 12471623 Free article.

4

High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.

Riemersma SA, Oudejans JJ, Vonk MJ, Dreef EJ, Prins FA, Jansen PM, Vermeer MH, Blok P, Kibbelaar RE, Muris JJ, Schuuring EM, Kluin PM. Riemersma SA, et al. J Pathol. 2005 Jul;206(3):328-36. doi: 10.1002/path.1783. J Pathol. 2005. PMID: 15887291

5

Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma.

Booman M, Douwes J, Glas AM, Riemersma SA, Jordanova ES, Kok K, Rosenwald A, de Jong D, Schuuring E, Kluin PM. Booman M, et al. Among authors: riemersma sa. Clin Cancer Res. 2006 May 1;12(9):2698-705. doi: 10.1158/1078-0432.CCR-05-2617. Clin Cancer Res. 2006. PMID: 16675561

6

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.

Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E, Kluin PM. Riemersma SA, et al. Blood. 2000 Nov 15;96(10):3569-77. Blood. 2000. PMID: 11071656 Free article.

7

The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.

Riemersma SA, Jordanova ES, Haasnoot GW, Drabbels J, Schuuring E, Schreuder GM, Kluin PM. Riemersma SA, et al. Hum Immunol. 2006 Apr-May;67(4-5):303-10. doi: 10.1016/j.humimm.2006.03.019. Epub 2006 Apr 7. Hum Immunol. 2006. PMID: 16720210

8

Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice.

Steeghs EMP, Vink GR, Elferink MAG, Voorham QJM, Gelderblom H, Nagtegaal ID; PATH Consortium Members; Grünberg K, Ligtenberg MJL; PATH consortium members. Steeghs EMP, et al. J Clin Pathol. 2021 Oct 21;75(10):706-11. doi: 10.1136/jclinpath-2021-207865. Online ahead of print. J Clin Pathol. 2021. PMID: 34675090 Free PMC article.

9

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

van der Wekken AJ, Pelgrim R, 't Hart N, Werner N, Mastik MF, Hendriks L, van der Heijden EHFM, Looijen-Salamon M, de Langen AJ, Staal-van den Brekel J, Riemersma S, van den Borne BE, Speel EJM, Dingemans AC, Hiltermann TJN, van den Berg A, Timens W, Schuuring E, Groen HJM. van der Wekken AJ, et al. Clin Cancer Res. 2017 Aug 1;23(15):4251-4258. doi: 10.1158/1078-0432.CCR-16-1631. Epub 2017 Feb 9. Clin Cancer Res. 2017. PMID: 28183714

10

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach.

Dekker TJ, ter Borg S, Hooijer GK, Meijer SL, Wesseling J, Boers JE, Schuuring E, Bart J, van Gorp J, Bult P, Riemersma SA, van Deurzen CH, Sleddens HF, Mesker WE, Kroep JR, Smit VT, van de Vijver MJ. Dekker TJ, et al. Among authors: riemersma sa. Breast Cancer Res Treat. 2015 Jul;152(2):253. doi: 10.1007/s10549-015-3478-0. Breast Cancer Res Treat. 2015. PMID: 26105796 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page